Glucagon-like peptide-1 7-36 amide - Restoragen

Drug Profile

Glucagon-like peptide-1 7-36 amide - Restoragen

Alternative Names: Betatropin; rGLP-1

Latest Information Update: 21 Aug 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Restoragen
  • Class Glucagon-like peptides
  • Mechanism of Action Glucagon-like peptide 1 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Obesity; Type 2 diabetes mellitus
  • Discontinued Cardiovascular disorders

Most Recent Events

  • 21 Aug 2003 No development reported - Phase-II for Obesity in USA (unspecified route)
  • 21 Aug 2003 No development reported - Phase-II for Type-2 diabetes mellitus in USA (unspecified route)
  • 05 Feb 2003 Rights to GLP-1 has been sold from Restoragen to Amylin for the treatment of congestive heart failure in patients ineligible for transplant
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top